Tarsus Pharmaceuticals (TARS)
US Market

Tarsus Pharmaceuticals Financial Statements


Tarsus Pharmaceuticals Financial Overview

Tarsus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.691; its P/E ratio is -6.09; Tarsus Pharmaceuticals is scheduled to report earnings on November 8, 2022, and the estimated EPS forecast is $-0.99. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 15.28M$ 539.00K$ 338.00K$ 1.24M$ 22.02M
Gross Profit$ 14.76M$ 506.00K$ 362.00K$ 1.18M$ 21.28M
EBIT$ -5.22M$ -19.52M$ -14.45M$ -15.71M$ 7.28M
EBITDA$ -5.13M$ -19.48M$ -14.41M$ -15.62M$ 7.41M
Net Income Common Stockholders$ -5.74M$ -20.24M$ -14.85M$ -15.70M$ 6.30M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 86.33M$ 156.18M$ 168.13M$ 171.81M$ 175.30M
Total Assets$ 252.83M$ 181.48M$ 178.91M$ 190.41M$ 203.45M
Total Debt$ 595.00K$ 677.00K$ 831.00K$ 1.19M$ 1.43M
Net Debt$ -85.73M$ -155.50M$ -167.30M$ -170.63M$ -173.87M
Total Liabilities$ 31.32M$ 32.29M$ 12.18M$ 11.27M$ 10.98M
Stockholders Equity$ 149.20M$ 165.98M$ 166.73M$ 179.14M$ 183.23M
Cash Flow
Free Cash Flow$ -4.38M$ -15.45M$ -12.39M$ 6.99M$ 20.54M
Operating Cash Flow$ -4.26M$ -15.29M$ -12.12M$ 7.11M$ 20.55M
Investing Cash Flow$ -122.00K$ -161.00K$ -274.00K$ -121.00K$ -16.00K
Financing Cash Flow$ 74.73M$ 19.13M$ -74.00K$ 75.00K$ 1.00K
Currency in USD

Tarsus Pharmaceuticals Earnings and Revenue History

Tarsus Pharmaceuticals Debt to Assets

Tarsus Pharmaceuticals Cash Flow

Tarsus Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis